AGIL THERAPEUTICS, INC.

Medtech

Duodenal cryoablation endoscopic system for controlled freezing of duodenal tissue to restore glucose control in Type 2 Diabetes

Grants
$275K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Treatment of Type 2 Diabetes through Cryoablation of the Duodenum$275,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1314FRESHAIR SENSOR CORPORATION—$32M
1315NEXTGENJANE INC—$19M
1316Etiometry Inc.—$8.2M
1317AGIL THERAPEUTICS, INC.——
1318BennuBio Inc—$6.8M
1319Triangle Biotechnology, Inc.——
1320VitaThreads LLC—$175K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Catheter, System, And Method For Selective Ablation In The Mucosa And Submucosa Of The Gastrointestinal Tractapplication
  • Cryogenic Catheter, System, And Method For Selective Ablation Of Mucosa And Submucosa Of The Gastrointestinal Tractapplication
  • Cryogenic Catheter, System, And Method For Selective Ablation Of Mucosa And Submucosa Of The Gastrointestinal Tractapplication
  • Cryogenic Catheter Probe, System, And Method For Selective Ablation Of Mucosa And Submucosa Of The Gastrointestinal Tractapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.